Trinity Biotech plc (TRIB) Reports In-Line Q3 EPS; Acquires Lab 21 in $7.5M Deal
Tweet Send to a Friend
Trinity Biotech plc (NASDAQ: TRIB) reported Q3 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
